Cargando…

Risk of head and neck cancer after chronic pancreatitis

BACKGROUND: To evaluate the relation of head and neck cancer to chronic pancreatitis by analyzing Taiwan’s National Health Insurance Research Database. METHODS: We identified 11,237 patients with chronic pancreatitis as the case cohort, which was propensity score matched with another 11,237 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chien-Hua, Chen, Chung-Hung, Lin, Cheng-Li, Hsu, Chung Y., Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154396/
https://www.ncbi.nlm.nih.gov/pubmed/32309360
http://dx.doi.org/10.21037/atm.2020.01.40
_version_ 1783521807635054592
author Chen, Chien-Hua
Chen, Chung-Hung
Lin, Cheng-Li
Hsu, Chung Y.
Kao, Chia-Hung
author_facet Chen, Chien-Hua
Chen, Chung-Hung
Lin, Cheng-Li
Hsu, Chung Y.
Kao, Chia-Hung
author_sort Chen, Chien-Hua
collection PubMed
description BACKGROUND: To evaluate the relation of head and neck cancer to chronic pancreatitis by analyzing Taiwan’s National Health Insurance Research Database. METHODS: We identified 11,237 patients with chronic pancreatitis as the case cohort, which was propensity score matched with another 11,237 patients without chronic pancreatitis by sex, age, index year, and comorbidities. We followed both cohorts between January 1, 2000, and December 31, 2011 to measure the incidence of head and neck cancer. RESULTS: Compared with patients without chronic pancreatitis, those with chronic pancreatitis were associated a greater risk of head and neck cancer [adjusted HR (aHR) =1.31, 95% confidence interval (CI): 1.07–1.60] and had a higher incidence of head and neck cancer (log-rank test, P<0.001). The experimental event rate of head and neck cancer for the chronic pancreatitis cohort was 1.90% (213/11,237) and control event rate of head and neck cancer for the non-chronic pancreatitis cohort was 1.60% (180/11,237), respectively. Therefore, the chronic pancreatitis cohort had a 0.30% of absolute risk increase and approximately 333 of number needed to harm for the development of head and neck cancer, respectively. Compared with the individuals without chronic pancreatitis and any other comorbidity, the risk of head and neck cancer for the chronic pancreatitis patients without comorbidities was 2.79 folds and the risk increased to 4.32, 3.33, 3.22, 4.44, and 5.78 folds in the presence of any one, any two, any three, any four, and more than five comorbidities, respectively. CONCLUSIONS: Chronic pancreatitis is related to an increased risk of head and neck cancer, and the presence of comorbidity increases the risk more. It requires more studies to find more co-existing risk factors or comorbidities to recommend a screening program for the CP patients. Moreover, it needs more studies to ascertain the pathogenesis for the aforementioned association and the limited knowledge of the patients' smoking habits and alcohol drinking is the major limitation of this observational study.
format Online
Article
Text
id pubmed-7154396
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-71543962020-04-17 Risk of head and neck cancer after chronic pancreatitis Chen, Chien-Hua Chen, Chung-Hung Lin, Cheng-Li Hsu, Chung Y. Kao, Chia-Hung Ann Transl Med Original Article BACKGROUND: To evaluate the relation of head and neck cancer to chronic pancreatitis by analyzing Taiwan’s National Health Insurance Research Database. METHODS: We identified 11,237 patients with chronic pancreatitis as the case cohort, which was propensity score matched with another 11,237 patients without chronic pancreatitis by sex, age, index year, and comorbidities. We followed both cohorts between January 1, 2000, and December 31, 2011 to measure the incidence of head and neck cancer. RESULTS: Compared with patients without chronic pancreatitis, those with chronic pancreatitis were associated a greater risk of head and neck cancer [adjusted HR (aHR) =1.31, 95% confidence interval (CI): 1.07–1.60] and had a higher incidence of head and neck cancer (log-rank test, P<0.001). The experimental event rate of head and neck cancer for the chronic pancreatitis cohort was 1.90% (213/11,237) and control event rate of head and neck cancer for the non-chronic pancreatitis cohort was 1.60% (180/11,237), respectively. Therefore, the chronic pancreatitis cohort had a 0.30% of absolute risk increase and approximately 333 of number needed to harm for the development of head and neck cancer, respectively. Compared with the individuals without chronic pancreatitis and any other comorbidity, the risk of head and neck cancer for the chronic pancreatitis patients without comorbidities was 2.79 folds and the risk increased to 4.32, 3.33, 3.22, 4.44, and 5.78 folds in the presence of any one, any two, any three, any four, and more than five comorbidities, respectively. CONCLUSIONS: Chronic pancreatitis is related to an increased risk of head and neck cancer, and the presence of comorbidity increases the risk more. It requires more studies to find more co-existing risk factors or comorbidities to recommend a screening program for the CP patients. Moreover, it needs more studies to ascertain the pathogenesis for the aforementioned association and the limited knowledge of the patients' smoking habits and alcohol drinking is the major limitation of this observational study. AME Publishing Company 2020-03 /pmc/articles/PMC7154396/ /pubmed/32309360 http://dx.doi.org/10.21037/atm.2020.01.40 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Chen, Chien-Hua
Chen, Chung-Hung
Lin, Cheng-Li
Hsu, Chung Y.
Kao, Chia-Hung
Risk of head and neck cancer after chronic pancreatitis
title Risk of head and neck cancer after chronic pancreatitis
title_full Risk of head and neck cancer after chronic pancreatitis
title_fullStr Risk of head and neck cancer after chronic pancreatitis
title_full_unstemmed Risk of head and neck cancer after chronic pancreatitis
title_short Risk of head and neck cancer after chronic pancreatitis
title_sort risk of head and neck cancer after chronic pancreatitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154396/
https://www.ncbi.nlm.nih.gov/pubmed/32309360
http://dx.doi.org/10.21037/atm.2020.01.40
work_keys_str_mv AT chenchienhua riskofheadandneckcancerafterchronicpancreatitis
AT chenchunghung riskofheadandneckcancerafterchronicpancreatitis
AT linchengli riskofheadandneckcancerafterchronicpancreatitis
AT hsuchungy riskofheadandneckcancerafterchronicpancreatitis
AT kaochiahung riskofheadandneckcancerafterchronicpancreatitis